New residents at our Main Campus

November 25, 2021

Our newest residents are slowly getting ready to finally move into our new Switzerland Innovation Park Basel Area Site opening in 2022, in close collaboration with our partner SENN Development. Find out more about them, and why they choose to move into our Main Campus.

T3 Pharmaceuticals

T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviors of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads into the cells.

Basilea Pharmaceutical AG

Basilea Pharamceutica AG is a commercial stage biopharmaceutical company, focused on the development of products that address the medical challenges in the therapeutic areas of oncology and anti-infectives.

HORTUS – The eco-friendly office space

Exciting things are happening next door to our Main Camps in Allschwil. SENN Development, Herzog & de Meuron, and ZPF Engineers are jointly developing an office building with approx. 10,000 m2 of usable space for environmentally conscious (tech) companies. The building sets a new standard for sustainability: It pays back the grey building energy and is already energy-positive after about 30 years. Learn more here.

You may also like